HIV gp160 vaccine
Alternative Names: 5 env5; HIVAC-1e; V env5Latest Information Update: 04 Apr 2022
At a glance
- Originator sanofi pasteur
- Developer Nonindustrial source; sanofi pasteur; Transgene
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 21 May 2007 Discontinued - Phase-I for HIV infections treatment in France (unspecified route)
- 21 May 2007 Discontinued - Phase-I for HIV infections treatment in USA (unspecified route)
- 21 May 2007 Discontinued - Preclinical for HIV infections treatment in Canada (unspecified route)